Ginsenoside Rg3 Reduces Lipid Accumulation with AMP-Activated Protein Kinase (AMPK) Activation in HepG2 Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2012 Jul 4

PMID 22754327

Citations 36

Authors

Seohyun Lee

Mak-Soon Lee

Chong-Tai Kim

In-Hwan Kim

Yangha Kim

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) is one of the main causes of mortality worldwide, and dyslipidemia is a major risk factor for CVD. Ginseng has been widely used in the clinic to treat CVD. Ginsenoside Rg3, one of the major active components of ginseng, has been reported to exhibit antiobesity, antidiabetic, and cardioprotective effects. However, the effect of ginsenoside Rg3 on hepatic lipid metabolism remains unclear. Therefore, we investigated whether ginsenoside Rg3 would regulate hepatic lipid metabolism with AMP-activated protein kinase (AMPK) activation in HepG2 cells. Ginsenoside Rg3 significantly reduced hepatic cholesterol and triglyceride levels. Furthermore, ginsenoside Rg3 inhibited expression of sterol regulatory element binding protein-2 (SREBP-2) and 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGCR). Ginsenoside Rg3 increased activity of AMPK, a major regulator of energy metabolism. These results suggest that ginsenoside Rg3 reduces hepatic lipid accumulation with inhibition of SREBP-2 and HMGCR expression and stimulation of AMPK activity in HepG2 cells. Therefore, ginsenoside Rg3 may be beneficial as a food ingredient to lower the risk of CVD by regulating dyslipidemia.

Citing Articles

[Protective Effect of Ginsenoside Rg3 on Lipopolysaccharide-Induced Neuronal-Galial Interaction Injury Model].

Cai X, Yang D, Zhuo X, Sun Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1543-1549.

PMID: 39990819 PMC: 11839363. DOI: 10.12182/20241160507.

Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases.

Jiang X, Wang H, Nie K, Gao Y, Chen S, Tang Y Chin Med. 2024; 19(1):120.

PMID: 39232826 PMC: 11373146. DOI: 10.1186/s13020-024-00988-w.

The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms.

Wang W, Li K, Xiao W J Ginseng Res. 2024; 48(2):129-139.

PMID: 38465219 PMC: 10920009. DOI: 10.1016/j.jgr.2023.11.004.

The impact of the administration of red ginseng () on lipid metabolism and free fatty acid profiles in healthy horses using a molecular networking approach.

Kwak Y, Hyun Yoo H, Yoon J Front Vet Sci. 2024; 11:1285000.

PMID: 38332753 PMC: 10851614. DOI: 10.3389/fvets.2024.1285000.

Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution.

Qiu R, Zhang J, Ge C, Zhong Y, Liu S, Li Q Evid Based Complement Alternat Med. 2022; 2022:1897508.

PMID: 36276866 PMC: 9583863. DOI: 10.1155/2022/1897508.

References

Chen Q, Reimer R . Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition. 2008; 25(3):340-9. PMC: 3827015. DOI: 10.1016/j.nut.2008.08.012. View

Kang K, Yamabe N, Kim H, Park J, Yokozawa T . Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. Biol Pharm Bull. 2010; 33(6):1077-81. DOI: 10.1248/bpb.33.1077. View

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

Park M, Ha J, Chung S . 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol Pharm Bull. 2008; 31(4):748-51. DOI: 10.1248/bpb.31.748. View

Yeo C, Lee S, Popovich D . Ginseng (Panax quinquefolius) Reduces Cell Growth, Lipid Acquisition and Increases Adiponectin Expression in 3T3-L1 Cells. Evid Based Complement Alternat Med. 2011; 2011:610625. PMC: 3136732. DOI: 10.1093/ecam/neq051. View

Brown M, Goldstein J . The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89(3):331-40. DOI: 10.1016/s0092-8674(00)80213-5. View

Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Herscovitz H . AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem. 2004; 279(46):47898-905. DOI: 10.1074/jbc.M408149200. View

Huang J, Tang X, Ikejima T, Sun X, Wang X, Xi R . A new triterpenoid from Panax ginseng exhibits cytotoxicity through p53 and the caspase signaling pathway in the HepG2 cell line. Arch Pharm Res. 2008; 31(3):323-9. DOI: 10.1007/s12272-001-1159-8. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Horton J, Shimomura I, Brown M, Hammer R, Goldstein J, Shimano H . Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest. 1998; 101(11):2331-9. PMC: 508822. DOI: 10.1172/JCI2961. View

11.

Lim S, Yoon J, Choi S, Cho B, Kim J, Chang H . Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism. 2008; 58(1):8-15. DOI: 10.1016/j.metabol.2008.07.027. View

12.

Steinberg G, Kemp B . AMPK in Health and Disease. Physiol Rev. 2009; 89(3):1025-78. DOI: 10.1152/physrev.00011.2008. View

13.

Carling D, Mayer F, Sanders M, Gamblin S . AMP-activated protein kinase: nature's energy sensor. Nat Chem Biol. 2011; 7(8):512-8. DOI: 10.1038/nchembio.610. View

14.

Lu J, Yao Q, Chen C . Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009; 7(3):293-302. PMC: 2928028. DOI: 10.2174/157016109788340767. View

15.

Kim S, Lee J, Shin H, Son S, Kim Y . Effects of in vitro-digested ginsenosides on lipid accumulation in 3T3-L1 adipocytes. Planta Med. 2009; 75(6):596-601. DOI: 10.1055/s-0029-1185358. View

16.

Horton J, Goldstein J, Brown M . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002; 109(9):1125-31. PMC: 150968. DOI: 10.1172/JCI15593. View

17.

Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R . AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf). 2009; 196(1):81-98. PMC: 2956117. DOI: 10.1111/j.1748-1716.2009.01970.x. View

18.

Lee J, Lim K, Kim S, Bae O, Noh J, Chung S . Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng. Toxicol Sci. 2010; 117(2):505-14. DOI: 10.1093/toxsci/kfq201. View

19.

Park I, Piao L, Kwon S, Lee Y, Cho S, Park M . Cytotoxic dammarane glycosides from processed ginseng. Chem Pharm Bull (Tokyo). 2002; 50(4):538-40. DOI: 10.1248/cpb.50.538. View

20.

Hwang J, Lee M, Kim H, Sung M, Kim H, Kim M . Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res. 2008; 23(2):262-6. DOI: 10.1002/ptr.2606. View